Randomized Controlled Comparison of Titanium-Sapphire Versus Standard Q-Switched Nd: YAG Laser Trabeculoplasty

Journal of Glaucoma
Kevin KaplowitzNils A Loewen

Abstract

To evaluate the clinical effects of laser trabeculoplasty using a novel 790 nm wavelength titanium-sapphire laser (TLT) compared with a 532 nm Q-switched Nd:YAG laser used in standard selective laser trabeculoplasty (SLT). Single institution prospective clinical trial of open-angle glaucoma patients randomized to TLT or SLT at the Yale Eye Center from 2011 to 2012. Patients with previous glaucoma surgery or trabeculoplasty were excluded. Trabeculoplasty was performed by a single surgeon unmasked to treatment group. All patients received 360 degrees of treatment. The main outcome measure was intraocular pressure (IOP) at 2 years. Thirty-seven patients were enrolled. The mean baseline IOPs were 19.7 in TLT (n=18) and 20.4 mm Hg in SLT (n=19, P=0.69).At 2 years, the mean IOP was 12.9 mm Hg (35% decrease, P<0.001) in the TLT group and 15.4 mm Hg (25% decrease, P=0.006) in the SLT group. The 2 groups did not differ in glaucoma medication use. Success, defined as IOP<21 mm Hg with >20% reduction from baseline without the need for secondary glaucoma procedures, occurred in 44% of TLT patients and 61% of SLT patients at 1 year and in 22% of TLT patients and 46% of SLT patients at 2 years (P=0.11). No patients experienced significant pa...Continue Reading

References

Feb 1, 1979·Archives of Ophthalmology·J B Wise, S L Witter
Jul 1, 1991·Ophthalmology·R M FeldmanM A Ali
Jan 15, 1989·American Journal of Ophthalmology·T S AcottE M Van Buskirk
Apr 1, 1988·Archives of Ophthalmology·S S BylsmaE M Van Buskirk
Sep 1, 1987·Ophthalmology·C U RichterL P Jacobson
Oct 1, 1985·Archives of Ophthalmology·S MelamedD L Epstein
Sep 1, 1984·Ophthalmology·E M Van BuskirkT S Acott
Nov 1, 1984·Archives of Ophthalmology·R C Spurny, C M Lederer
Mar 1, 1983·American Journal of Ophthalmology·R N WeinrebK Zweig
Jan 1, 1994·International Ophthalmology Clinics·S D Smith, P A Netland
Apr 25, 2006·Journal of Glaucoma·Ian McIlraithCindy M L Hutnik
Oct 4, 2006·Archivos de la Sociedad Española de Oftalmología·G Simón
Feb 16, 2007·Current Opinion in Ophthalmology·Joshua D Stein, Pratap Challa
Sep 8, 2007·Experimental Eye Research·Douglas H Johnson
Mar 20, 2009·Journal of Glaucoma·Bryan Kun HongBruce Shields
Jun 3, 2009·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Modi GoldenfeldGuy J Ben Simon
Jun 1, 2008·Clinical Ophthalmology·Antonio Maria FeaFederico Maria Grignolo
Apr 1, 1994·Journal of Glaucoma·S S BylsmaE M Van Buskirk
Jun 24, 2010·American Journal of Ophthalmology·Jorge A AlvaradoAmde Selassie Shifera
Aug 6, 2011·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Vasilios TzimisCatherine Mary Birt
Jan 17, 2012·American Journal of Ophthalmology·Steven J GeddeUNKNOWN Tube versus Trabeculectomy Study Group
Apr 14, 2012·Investigative Ophthalmology & Visual Science·Andrew W FrancisJoel S Schuman
Jun 12, 2012·Ophthalmology·Larry KagemannJoel S Schuman
Jun 19, 2013·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Hao WangXiao-Ye Ma
Jul 13, 2013·Investigative Ophthalmology & Visual Science·Julius T OattsNils A Loewen

❮ Previous
Next ❯

Citations

Sep 11, 2018·Eye & Contact Lens·Xuemin ZhangOsamah Saeedi
Nov 20, 2020·International Ophthalmology·Bhawesh Chandra SahaSanjeev Kumar
Sep 6, 2020·American Journal of Ophthalmology·Rouxi ZhouWei Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.